New way to develop medicines free of side effects

Image
Press Trust of India Washington
Last Updated : Jul 08 2018 | 4:50 PM IST

A new technique for precisely targeting molecules within cells may pave the way for medicines that are free of side effects, scientists say.

Researchers from the University of Virginia in the US have developed a way to manipulate molecules from compartment to compartment within individual cells.

The same molecules do different things depending on their location, the researchers determined. By manipulating the molecules, scientists can determine exactly which locations to target, while avoiding locations that would cause harmful side effects.

"The problem with side effects is caused because you just could not distinguish the molecules doing different things in the same cell," said J Julius Zhu, from University of Virginia.

"If you blocked a molecule, you blocked it regardless of what it was doing. And that usually has unwanted side effects. Almost every drug that can treat disease has side effects, either major or minor, but usually they always have something," said Zhu.

Until now, drugs have targeted molecules in a very general way. If a molecule was thought to be harmful, researchers might try to develop a drug to block it entirely.

However, Zhu's work highlights the downside of that shotgun approach. A molecule might be causing problems because of what it is doing in one part of the cell, but, at the same time, that same molecule is doing something entirely different in other parts - perhaps something tremendously important.

Shutting it down entirely would be like trying to solve the problem of traffic congestion by banning cars.

Rather than crudely trying to block a molecule regardless of its many functions, doctors can target a specific molecule doing a specific thing in a specific location.

That adds a new level of precision to the concept of precision medicine - medicine tailored exactly to a patient's needs.

The technique will be useful for many different diseases, but especially for cancers and neurological conditions such as autism and Alzheimer's.

The technique will also speed up the development of new treatments by letting researchers more quickly understand what molecules are doing and which should be targeted.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 08 2018 | 4:50 PM IST

Next Story